Rigel Pharmaceuticals
RIGL
RIGL
113 hedge funds and large institutions have $176M invested in Rigel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 10 closing their positions.
Holders
113
Holders Change
+7
Holders Change %
+6.6%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
38
Reduced
28
Closed
10
Calls
$1.39M
Puts
$77K
Net Calls
+$1.31M
Net Calls Change
+$515K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$41.9M |
2 |
2
BlackRock
New York
|
$22M |
3 |
GCP
3
GSA Capital Partners
London,
United Kingdom
|
$2.07M |
4 |
4
Squarepoint
New York
|
$469K |
5 |
ZIM
5
Zacks Investment Management
Chicago,
Illinois
|
$438K |